Arcutis Biotherapeutics ($ARQT) Insider Trading & Smart Money Activity
Arcutis Biotherapeutics, Inc. ($ARQT) has 3 insider trades, 1 congress trade and 5 13F position changes on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($228.74K), net -$228.74K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$228.74K
- Congress trades (12 mo)
- 1
- 13F moves on file
- 5
- Analyst ratings on file
- 0
ARQT insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $136.88K | 1 / 0 | 3 / 2 |
| Q3 2026 | 0 | 1 · $91.85K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ARQT insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Matsuda MasaruReporting Person's title: EVP, Chief Legal Officer | Sell (Open-market sale) 10b5-1 | 3.67K sh | $91.85K | +0.9% | +10.3% | — | ||||
| Insider | Howard Welgus | Sell (Open-market sale) 10b5-1 | 635 sh | $16.30K | +4.4% | +8.7% | Read | ||||
| Insider | Sue-Jean Lin | Sell (Open-market sale) 10b5-1 | 4.95K sh | $120.58K | +4.2% | +8.6% | Read | ||||
| Congress | Gilbert Cisneros | Purchase | $1,001 - $15,000 | -1.1% | +24.7% | Read | |||||
| 13F | Squarepoint Ops | Added | +647.61K sh | $27.13M | -2.2% | +20.0% | — | ||||
| 13F | Squarepoint Ops | Added | +647.61K sh | $28.93M | -2.2% | +20.0% | — | ||||
| 13F | Marshall Wace | Added | +1.98M sh | $63.76M | -2.2% | +20.0% | Read | ||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -140K sh | +4.4% | +4.3% | — | |||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -140K sh | +4.4% | +4.3% | — |
1W / 1M / 6M = how ARQT moved from the trade or filing date.
Insider trading in ARQT: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Matsuda Masaru | Reporting Person's title: EVP, Chief Legal Officer | 1 | -$91.85K | Sep 16, 2026 | |
| Howard Welgus | 1 | -$16.30K | Jun 17, 2026 | ||
| Sue-Jean Lin | 1 | -$120.58K | Jun 15, 2026 |
Members of Congress trading ARQT
Institutions moving ARQT (13F)
Frequently asked questions
Are ARQT insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $228.74K, a net -$228.74K.
What is the latest insider trade in ARQT?
Matsuda Masaru, Reporting Person's title: EVP, Chief Legal Officer filed a sell (open-market sale) of 3.67K sh worth $91.85K on Sep 16, 2026.
Which members of Congress traded ARQT?
1 disclosed trade by Gilbert Cisneros. The latest was on May 29, 2026.
Which institutions changed their ARQT positions?
Recent 13F filers moving the stock include Squarepoint Ops, Dekabank Deutsche Girozentrale and Marshall Wace.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.